Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KOSDAQ/115450 stock hub

KOSDAQ/115450 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/115450is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
308.2B
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/115450
In the news

Latest news · KOSDAQ/115450

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 9.8P50 17.1P75 31.9
Trailing P/En/a
P25 12P50 23.1P75 39.5
ROE-5.4
P25 -17.1P50 0.7P75 8.5
ROIC-2.1
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/115450 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
198
Groups with data
11
Currency
KRW
Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
49
Enterprise value
KRW 326.4B
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Biotechnology
Isin
KR7115450009
Last refreshed
2026-05-10
Market cap
KRW 308.2B
Price
KRW 3,330
Price currency
KRW
Rev Per Employee
1,419,619,465.71x
Sector
Healthcare
Sic
2836
Symbol
kosdaq/115450
Website
https://hlbtherapeutics.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-2.99%
EV Earnings
-35.38x
EV/FCF
-34.49x
EV/Sales
4.69x
FCF yield
-3.07%
P/B ratio
1.77x
P/S ratio
4.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
-5.15%
EBITDA Margin
1.5%
Gross margin
14.42%
Gross Profit
KRW 10B
Gross Profit Growth
0.53%
Gross Profit Growth Q
67.11%
Gross Profit Growth3 Y
4.78%
Gross Profit Growth5 Y
9.18%
Net Income
KRW -9.2B
Net Income Growth Q
-65.78%
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Pretax Margin
-15.94%
Profit Margin
-13.26%
Profit Per Employee
KRW -188.3M
ROA
-1
Roa5y
-2.61
ROCE
-1.77
ROE
-5.44
Roe5y
-8.96
ROIC
-2.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
-8.82%
Cagr15y
0.57%
Cagr1y
-56.04%
Cagr3y
-8.47%
Cagr5y
-9.84%
EPS Growth Q
-69.5
EPS Growth Quarters
1
EPS Growth Years
1
FCF Growth Q
-93.02%
OCF Growth Q
-92.86%
Revenue Growth
26.63x
Revenue Growth Q
38.36x
Revenue Growth Quarters
5x
Revenue Growth Years
3x
Revenue Growth3 Y
17.94x
Revenue Growth5 Y
10.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
KRW 0.31
Assets
KRW 228.7B
Cash
KRW 46B
Current Assets
KRW 74.5B
Current Liabilities
KRW 26.2B
Debt
KRW 40.6B
Debt EBITDA
KRW 38.98
Debt Equity
KRW 0.23
Debt FCF
KRW -4.29
Equity
KRW 173.9B
Interest Coverage
-1.87
Liabilities
KRW 54.8B
Long Term Assets
KRW 154.2B
Long Term Liabilities
KRW 28.6B
Net Cash
KRW 5.4B
Net Cash By Market Cap
KRW 1.77
Net Cash Growth
-62.22%
Net Debt EBITDA
KRW -5.24
Net Debt Equity
KRW -0.03
Tangible Book Value
KRW 138.3B
Tangible Book Value Per Share
KRW 1,585
WACC
1.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.84
Inventory Turnover
9.44
Net Working Capital
KRW 14.5B
Quick ratio
2.31
Working Capital
KRW 48.3B
Working Capital Turnover
KRW 1.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-4.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-60.27%
1Y total return
-56.02%
200-day SMA
3,122.1
3Y total return
-23.31%
50-day SMA
3,164.1
50-day SMA vs 200-day SMA
50over200
5Y total return
-40.41%
All Time High
24,089.2
All Time High Change
-86.18%
All Time High Date
2018-04-09
All Time Low
872.1
All Time Low Change
281.83%
All Time Low Date
2014-01-08
ATR
186.9
Beta
-0.63
Beta1y
0.03
Beta2y
-0.24
Ch YTD
16.55
High
3,490
High52
9,857.1
High52 Date
2025-06-20
High52ch
-66.22%
Low
3,305
Low52
2,404.8
Low52 Date
2026-03-04
Low52ch
38.48%
Ma50ch
5.24%
Price vs 200-day SMA
6.66%
RSI
46.78
RSI Monthly
40.69
RSI Weekly
50.12
Sharpe ratio
-1.05x
Sortino ratio
-1.27
Total Return
-4.09%
Tr YTD
16.55
Tr15y
8.93%
Tr1m
9.36%
Tr1w
-8.64%
Tr3m
21.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
KRW -3.6B
Operating Income Growth Q
25,714.7
Operating margin
-5.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
81,219,740%
Net Borrowing
11,456,926,000
Shares Insiders
0.35%
Shares Institutions
3.44%
Shares Out
92,563,127
Shares Qo Q
-1%
Shares Yo Y
4.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
KRW -10.1B
Average Volume
918,631.4x
Bv Per Share
1,721.7
CAPEX
KRW -1.3B
Ch10y
-60.27
Ch15y
-14.13
Ch1m
9.36
Ch1w
-8.64
Ch1y
-56.02
Ch3m
21.41
Ch3y
-23.31
Ch5y
-40.41
Ch6m
1.06
Change
-3.76%
Change From Open
-4.45
Close
3,460
Days Gap
0.72
Depreciation Amortization
4,622,230,000
Dollar Volume
2,055,485,790
Earnings Date
2026-05-12
EBIT
KRW -3.6B
EBITDA
KRW 1B
EPS
KRW -105
F Score
3
FCF
KRW -9.5B
FCF EV Yield
-2.9x
FCF Per Share
KRW -102
Financing CF
11,124,198,830
Fiscal Year End
December
Founded
2,000
Goodwill
5,387,593,000
Income Tax
KRW -1.4B
Investing CF
-563,607,300
Is Primary Listing
1
Last Earnings Date
2026-02-20
Last Report Date
2025-12-31
Last Split Date
2026-03-12
Last Split Type
Forward
Ma150
3,057
Ma150ch
8.93%
Ma20
3,547.8
Ma20ch
-6.14%
Net CF
2,377,078,490
Next Earnings Date
2026-05-12
Open
3,485
Position In Range
13.51
Ppne
8,856,528,270
Price Date
2026-05-08
Price EBITDA
KRW 296
Ptbv Ratio
2.23
Relative Volume
0.68x
Revenue
69,561,353,820x
SBC By Revenue
0.87x
Share Based Comp
602,545,000
Tax By Revenue
-2.04x
Tr6m
1.06%
Volume
617,263
Z Score
6.21
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/115450 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/115450 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-56.0%
S&P 500 1Y: n/a
3Y total return
-23.3%
S&P 500 3Y: n/a
5Y total return
-40.4%
S&P 500 5Y: n/a
10Y total return
-60.3%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/115450?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.4%
Share of float held by funds and institutions
Insider ownership
+0.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+4.1%
Negative means the company is buying back shares.
Technical

KOSDAQ/115450 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
46.8
Neutral momentum band
Price vs 200-day MA
+6.7%
50/200-day relationship not available
Beta (5Y)
-0.63
Less volatile than the market
Sharpe ratio
-1.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/115450

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/115450 stock rating?

kosdaq/115450 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/115450 analysis?

The full report lives at /stocks/kosdaq/115450/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/115450?

The latest report frames kosdaq/115450 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/115450 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.